Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech success, 2002 -- Ignore unavailable to you. Want to Upgrade?

To: Miljenko Zuanic who wrote (58)	4/30/2002 6:54:06 AM
From: dalroi	Read Replies (1) \| Respond to of 117

Miljenko i think they're playing a poker game ie They look at how low first secund and third tier biotech can drop (are dropping) so it becomes easier for them to buy them 1-2 years ago it was impossible to buy a mlnm at 30$/s sepr at 24$/s incy at 20 $/s now those figures would be a lofty premy to the MC so lots would sell there is only one problem with this strategy which worked well till now. Thats when the feeding frenzy start not one of the biggies would be left alone. think its time to make a possible takeover targetlist Just like Peters munch list gonna try to set one up ELN SEPR MLNM GILD VRTX ?? celltech ? my favorite would be eln 1/ earnings 2/ lot of small biotech investments 3/ price beaten down by accounting but once a biggie takes them over that shouldnt be a problem first tier still to expensive for munch cheers Stefaan